Pregled bibliografske jedinice broj: 1057810
Traumatic brain injury: pathophysiology and neuroprotective therapy
Traumatic brain injury: pathophysiology and neuroprotective therapy // 9. Hrvatski kongres farmakologije s međunarodnim sudjelovanjem - zbornik sažetaka
Zagreb: Hrvatsko društvo farmakologa, 2019. str. 53-54 (pozvano predavanje, domaća recenzija, sažetak, znanstveni)
CROSBI ID: 1057810 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Traumatic brain injury: pathophysiology and
neuroprotective therapy
Autori
Pilipović, Kristina ; Dolenec, Petra ; Rajič Bumber, Jelena ; Janković, Tamara ; Gržeta, Nika ; Župan, Željko ; Križ, Jasna ; Župan, Gordana
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
9. Hrvatski kongres farmakologije s međunarodnim sudjelovanjem - zbornik sažetaka
/ - Zagreb : Hrvatsko društvo farmakologa, 2019, 53-54
Skup
9. hrvatski kongres farmakologije = 9th Croatian Congress of Pharmacology
Mjesto i datum
Zagreb, Hrvatska, 25.09.2019. - 28.09.2019
Vrsta sudjelovanja
Pozvano predavanje
Vrsta recenzije
Domaća recenzija
Ključne riječi
neuroprotection ; pathophysiology ; traumatic brain injury
Sažetak
Traumatic brain injury (TBI) is a major cause of death and long-term disability, especially in previously healthy young people. It is also associated with increased posttraumatic incidence of different diseases and disturbances such as neurodegenerative, psychiatric, cognitive and sleep disorders, systemic metabolic and neuroendocrine dysregulations, sexual dysfunction, etc., many of them lifelong. The most frequent causes of single TBI are falls and motor vehicle accidents while the repetitive form is more often associated with contact sports, domestic spousal violence, child abuse or blast injuries. Because of all the above mentioned, TBI presents a significant public health problem all over the world. It is a complex continuous disease process that includes different events with subsequent brain tissue damage. Although numerous preclinical and clinical studies were done in order to clarify the pathophysiology of the brain trauma, all the mechanisms involved in the brain structures’ damage still remain unknown. Today's therapy of TBI patients is supportive and symptomatic. Clinically effective pharmacological neuroprotective therapy for TBI has not yet been established. Therefore, development of novel pharmacological treatment options is of the highest priority. Today, special attention is on multifunctional drugs that affect different processes of brain damage in TBI. In this talk, an overview of current knowledge on the pathophysiology of single and repetitive mild TBI as well as on different neuroprotective therapeutic strategies, including our recent results in this field, will be presented. This work was supported in parts by Croatian Science Foundation, project IP-2016-064602 to Ž.G., University of Rijeka, projects uniri- biomed-18-204 to Ž.G. and uniri-biomed-18-199 to P.K., and Ministry of Science, Education, and Sports of the Republic of Croatia, project 062-0620529-0519 to Ž.G.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
MZOS-062-0620529-0519 - Epilepsija i traumatska ozljeda mozga: mehanizmi oštećenja i farmakoterapija (Župan, Gordana, MZOS ) ( CroRIS)
MEDRI--uniri-biomed-18-204 - Patofiziologija i neuroprotektivno liječenje u modelu traumatske ozljede mozga u štakora (Župan, Gordana; Dolenec, Petra, MEDRI ) ( CroRIS)
MEDRI--uniri-biomed-18-199 - Molekularni mehanizmi neurodegeneracije u traumatskoj ozljedi mozga: uloga TAR DNA-vezujućeg proteina 43 (Pilipović, Kristina, MEDRI ) ( CroRIS)
IP-2016-064602
Ustanove:
Medicinski fakultet, Rijeka,
Klinički bolnički centar Rijeka
Profili:
Željko Župan
(autor)
Jelena Rajič Bumber
(autor)
Gordana Župan
(autor)
Tamara Janković
(autor)
Kristina Pilipović
(autor)
Petra Dolenec
(autor)
Jasna Križ
(autor)
Nika Gržeta
(autor)